- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04111900
Effect of Sleep on the Recovery of Patients Admitted to the ICU
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Critically ill patients are known to suffer from severely fragmented sleep with a predominance of stage I sleep and a paucity of slow wave and REM sleep. The causes of this sleep disruption include the intensive care unit (ICU) environment, medical illness, psychological stress, and many of the medications and other treatments used to help those who are critically ill. Surveys have identified poor sleep as one of the most frequent complaints among patients who have survived a critical illness. Patients in medical, cardiac, and surgical ICUs almost uniformly have fragmented sleep.
Although illness, pain, and medications contribute to sleep disruption in ICU patients, the primary factor causing sleep disruption had been thought to be the ICU environment. Noise from various sources, including ventilators, alarms, television, phones, beepers, and conversation, have all been purported to disturb sleep in the ICU. Patients have reported that noise, specifically talking, is a frequent cause of sleep disruption in the ICU. Several studies have confirmed that peak noise levels in ICUs are far in excess of 45 dB during the day and 35 dB at night, which are the recommendations of the Environmental Protection Agency for peak noise levels in the ICU.
The clinical importance of this type of sleep disruption in critically ill patients, however, is not known. The investigators hope to determine if placing patients in sleep/circadian rhythm friendly rooms will enable them to achieve better sleep, suffer from decreased delirium, and have improved recovery from their critical illness.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- any adult patient admitted to the MICU with an expected length of stay of at least 3 days
Exclusion Criteria:
- frequent overnight neurological checks or frequent peripheral vascular checks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sleep/Circadian Friendly
initiation of sleep/circadian rhythm friendly intervention the first night spent in MICU after enrollment until patient transfers/discharges, ceases participation, or meets exclusion criteria.
|
This intervention attempts to improve sleep and prevent circadian rhythm dysregulation among patients admitted to the medical intensive care unit (MICU).
Patients within his arm will be asked to try to keep their TV off and limit their telephone use from 10pm-7am, as well as limit the amount of visitors in their room as much as possible between those hours.
Patients will also be offered ear plugs and eye masks if they wish to use at night to aid in helping them sleep, if deemed medically safe to do so.
Additionally nurses will be asked to bathe patients either before 10pm or after 7am, to limit their conversations in the patient's room at night, and try as much as possible to limit blood draws and waking patients during those hours as is medically safe.
Nurses will also be instructed to lower the blinds in the room at 10 pm and raise them up at 7am to help with patients sleep/wake cycle.
|
No Intervention: Usual Care
Usual care within intensive care unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of Stay in ICU
Time Frame: through study completion, an average of 3-4 days
|
Time spent from admission to ICU until transfer/discharge or study cessation
|
through study completion, an average of 3-4 days
|
Overall Hospital Length of Stay
Time Frame: at study completion, an average of 5-7 days
|
Total time spent from admission to ICU until discharge from hospital
|
at study completion, an average of 5-7 days
|
Rate of ICU mortality
Time Frame: at study completion, up to 30 days
|
rate of mortality while admitted to ICU
|
at study completion, up to 30 days
|
Rate of Delirium
Time Frame: Once daily throughout study, on average 3-4 days
|
Assess development of delirium through administration of CAM-ICU and RASS performed daily by nursing staff per routine care.
Delirium will be considered present if CAM-ICU is positive or RASS above +1 or below -1 at anytime during study.
|
Once daily throughout study, on average 3-4 days
|
Hospital Readmission Rate
Time Frame: 30 days after discharge
|
rate of hospital readmission within 30-days of discharge
|
30 days after discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ICU sleep score
Time Frame: daily through study completion, an average of 3-4 days
|
Assess sleep quality through administration of Richard Campbell Sleep Questionnaire (RCSQ).
RCSQ is a simple and validated survey to measure sleep quality in ICU settings.
RCSQ consists of a series of 8 patient reported questions covering sleep depth, sleep latency, total amount of sleep, number of awakenings, sleep quality, noise rating, light rating, and sleep quality compared to at home.
All questions are to be reported on a scale of 0-100 with higher values corresponding to better sleep values.
|
daily through study completion, an average of 3-4 days
|
Overnight Sound Intensity Levels
Time Frame: through study completion, an average of 3-4 days
|
sound intensity (decibel) within patient room with be continuously recorded through SDL-600 industrial decibel monitors.
|
through study completion, an average of 3-4 days
|
Overnight Light Intensity Exposure
Time Frame: through study completion, an average of 3-4 days
|
amount of light patients are exposed to overnight, measured in lux, will be continuously recorded through specialized medical lux monitors.
|
through study completion, an average of 3-4 days
|
Concentration of Interleukin-6 (IL-6) and interleukin-10 (IL-10)
Time Frame: Study Day 1 and Day 2
|
concentrations of IL-6 (pg/mL) and IL-10 (pg/mL), inflammatory cytokines found to play a role in circadian regulation, levels will be measured from approximately 2mL of plasma that will be collected concurrently during morning routine care lab draw.
|
Study Day 1 and Day 2
|
Concentration of 6-sulphatoxymelatonin (aMT6s)
Time Frame: Study Day 1 and Day 2
|
concentrations of 6-sulphatoxymelatonin (pg/mL), the primary urine metabolite of melatonin and circadian rhythm phase marker, will be measured from left-over voided urine collected from patients prior to discard.
|
Study Day 1 and Day 2
|
Concentration of Lipopolysaccharide binding protein (LBP)
Time Frame: Study Day 1 and Day 2
|
Levels of LBP (pg/mL), an acute phase protein that upregulates during an inflammatory physiologic state, will be measured from 2mL of blood taken concurrently with routine morning labs.
|
Study Day 1 and Day 2
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Garth R Swanson, MD, Rush University Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16111002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicRecruitingDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Menoufia UniversityCompleted
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Johns Hopkins UniversityNational Institute on Aging (NIA)Active, not recruitingDelirium | Delirium on Emergence | Hearing Loss | Hearing Loss, High-Frequency | Hearing Loss, Sensorineural | Delirium, Cause Unknown | Hearing Loss, Bilateral | Hearing Disability | Delirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional State | Delirium With... and other conditionsUnited States
-
Chinese PLA General HospitalBeijing Tiantan HospitalRecruiting
-
Charite University, Berlin, GermanyBARMERRecruitingDelirium in Old AgeGermany
-
Mayo ClinicCompletedPost-Operative DeliriumUnited States
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyRecruitingPostoperative Delirium (POD)Switzerland
Clinical Trials on Sleep/Circadian Friendly
-
Chinese University of Hong KongNot yet recruiting
-
Brigham and Women's HospitalNational Institute on Aging (NIA)CompletedAging | Sleep Restriction | Circadian DisruptionUnited States
-
University of MontanaUniversity of Nevada, Las VegasRecruitingInflammation | Sleep Deprivation | Smoke Inhalation | Circadian Rhythm Sleep Disorder, Shift Work TypeUnited States
-
University of ChicagoTerminatedSleep Deprivation | Circadian Dysregulation | Shift-Work Sleep DisorderUnited States
-
University of California, BerkeleyEnrolling by invitationImplementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: SustainmentSleep Wake Disorders | Circadian Rhythm DisordersUnited States
-
Brian GehlbachNational Heart, Lung, and Blood Institute (NHLBI)CompletedCritical Illness | Respiratory Failure | Sleep Deprivation | Sleep Disorders, Circadian RhythmUnited States
-
University of California, BerkeleyRecruitingSleep Disorder | Memory ImpairmentUnited States
-
University of California, BerkeleyUniversity of Pittsburgh; Alameda County Behavioral Health Care ServicesCompletedMental DisordersUnited States
-
University of ChicagoCompleted
-
University of California, BerkeleyRecruitingSleep Disorder | Circadian DysregulationUnited States